{
  "scan_date": "2026-02-28",
  "scan_time": "13:33",
  "version": "1.9.0",
  "stats": {
    "total_tickers": 60,
    "buy_signals": 0,
    "watchlist_signals": 11,
    "momentum_signals": 7,
    "tier1_qualified": 1,
    "tier2_qualified": 6,
    "growth_qualified": 5,
    "accel_qualified": 32,
    "quality_qualified": 24,
    "quality_winners": 28,
    "screener_candidates": 21,
    "convergence_signals": 19
  },
  "edge_buckets": [
    {
      "label": "WATCHLIST",
      "tickers": [
        "ADBE",
        "NBIS",
        "IREN",
        "TTD",
        "AGI",
        "GDDY",
        "BRCTF",
        "PYPL",
        "CRWV",
        "DSKYF",
        "PLTR"
      ]
    },
    {
      "label": "MOMENTUM",
      "tickers": [
        "MNKD",
        "ASTS",
        "AXSM",
        "REPL",
        "DTE",
        "ETN",
        "TVTX"
      ]
    }
  ],
  "opportunities": [
    {
      "ticker": "ADBE",
      "score": 97,
      "recommendation": "WATCHLIST",
      "profile": "value",
      "tier": 5,
      "confidence": 56,
      "price": 262.41,
      "market_cap_fmt": "$109.8B",
      "down_from_high_pct": 42.1,
      "catalyst_type": null,
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": 3.02,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "profitability": 20,
        "fcf": 20,
        "discount": 15,
        "sector_panic": 15,
        "pe_discount": 15,
        "no_dilution": 11,
        "convergence_bonus": 8,
        "news_boost": 6,
        "breakout_pattern_bonus": 14,
        "claude_enhancement": -1,
        "ai_disruption": 8,
        "insider_sell_penalty": -10
      },
      "score_trend": [
        86,
        84,
        88,
        97,
        98,
        97,
        90,
        96,
        91,
        97
      ],
      "price_trend": [
        258.61,
        246.68,
        256.595,
        256.595,
        255.17,
        257.81,
        259.04,
        259.04,
        262.41,
        262.41
      ],
      "trend_direction": "stable",
      "aggregate": {
        "avg_score": 86,
        "peak_score": 115,
        "min_score": 50,
        "buy_pct": 68,
        "price_change_pct": -0.0
      },
      "fundamentals": {
        "pe": 15.7,
        "rev_growth_pct": 10.5,
        "margin_pct": 30.0,
        "target_price": 408.47,
        "target_upside_pct": 55.7,
        "target_median": 400.0,
        "target_high": 605.0,
        "target_low": 270.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 1,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 3,
          "buy": 17,
          "hold": 15,
          "sell": 4,
          "strong_sell": 0,
          "total": 39
        },
        "distribution_shift": {
          "buy_pct_change": -2.6,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "ANF",
        "correlation": 0.76,
        "phase": "Coiling",
        "months_est": 10.6
      },
      "ai_thesis": "Adobe's expanded partnership with WPP to deliver integrated marketing solutions for global brands positions the company to capture increased enterprise demand for AI-powered creative and marketing tools, providing an immediate catalyst for revenue growth acceleration. Trading 42% below its 52-week high at $262.41 despite strong bullish sentiment (87% on StockTwits), the current valuation presents an attractive entry point before partnership revenues materialize in upcoming quarters. The lack of insider buying activity has created temporary selling pressure, but the partnership's focus on enterprise solutions aligns with Adobe's strategic shift toward recurring revenue streams and AI integration across its Creative Cloud and Experience Cloud platforms.",
      "scans_tracked": 13,
      "first_detected": "2026-02-13T12:44:21.031878",
      "hysteresis_note": "BUY pending (streak 7/2, conf 56)",
      "events": [],
      "checklist": {
        "Profitable": "pass",
        "Strong FCF": "pass",
        "Near 52w Lows": "pass",
        "Sector Panic": "pass",
        "Low PE": "pass",
        "No Dilution": "pass"
      },
      "checklist_score": 6,
      "quality_framework": "value",
      "convergence_signal": true,
      "satellite_fit": 0.77,
      "satellite_score": 27,
      "entry_timing": {
        "score": 74,
        "label": "Wait",
        "recommended_entry": 265.69,
        "rsi": 39.9,
        "risk_reward": null,
        "entry_aging": "stale"
      }
    },
    {
      "ticker": "NBIS",
      "score": 94,
      "recommendation": "WATCHLIST",
      "profile": "recovery",
      "tier": 2,
      "confidence": 97,
      "price": 91.19,
      "market_cap_fmt": "$23.1B",
      "down_from_high_pct": 35.4,
      "catalyst_type": "earnings",
      "catalyst_date": "2026-05-18",
      "days_to_catalyst": 79,
      "short_interest_pct": 18.09,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "catalyst": 20,
        "fallen_angel": 15,
        "fundamental": 20,
        "social": 15,
        "news_boost": 7,
        "acceleration_influence": -7,
        "momentum_bonus": 7,
        "breakout_pattern_bonus": 5,
        "fundamental_risk": -11,
        "claude_enhancement": 1,
        "ai_disruption": 18
      },
      "score_trend": [
        47,
        69,
        39,
        52,
        47,
        47,
        47,
        47,
        90,
        94
      ],
      "price_trend": [
        97.92,
        97.92,
        100.61,
        102.136,
        102.136,
        102.58,
        104.88,
        104.88,
        91.19,
        91.19
      ],
      "trend_direction": "improving",
      "aggregate": {
        "avg_score": 55,
        "peak_score": 94,
        "min_score": 39,
        "buy_pct": 16,
        "price_change_pct": 2.9
      },
      "fundamentals": {
        "pe": 759.9,
        "rev_growth_pct": 5.0,
        "margin_pct": 19.2,
        "target_price": 147.45,
        "target_upside_pct": 61.7,
        "target_median": 150.0,
        "target_high": 232.0,
        "target_low": 70.0
      },
      "insider": {
        "signal": "NEUTRAL",
        "buys": 0,
        "sells": 0,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 2,
          "buy": 7,
          "hold": 2,
          "sell": 0,
          "strong_sell": 1,
          "total": 12
        },
        "distribution_shift": {
          "buy_pct_change": 5.0,
          "sell_pct_change": 8.3
        }
      },
      "trajectory": {},
      "ai_thesis": "NBIS presents a compelling buy opportunity following its transformative AI acquisition, which positions the company to capitalize on the rapidly expanding AI cloud infrastructure market with a catalyst timeline of approximately 79 days. The stock is trading 35% below its 52-week high at $91.19, creating an attractive entry point despite overwhelmingly bullish sentiment (91% on StockTwits) that suggests strong retail conviction ahead of acquisition integration milestones. With neutral insider activity indicating no competitive selling pressure and a high conviction score of 84/100, the risk-reward profile favors accumulation before the acquisition's value becomes fully reflected in the share price.",
      "scans_tracked": 10,
      "first_detected": "2026-02-12T09:32:03.067211",
      "hysteresis_note": "BUY pending (streak 1/2, conf 97)",
      "events": [],
      "checklist": {},
      "checklist_score": 0,
      "quality_framework": "",
      "convergence_signal": false,
      "satellite_fit": 1.03,
      "satellite_score": 53,
      "entry_timing": {
        "score": 82,
        "label": "Enter",
        "recommended_entry": 93.85,
        "rsi": 45.9,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "IREN",
      "score": 92,
      "recommendation": "WATCHLIST",
      "profile": "recovery",
      "tier": 2,
      "confidence": 95,
      "price": 40.95,
      "market_cap_fmt": "$13.6B",
      "down_from_high_pct": 46.7,
      "catalyst_type": "earnings",
      "catalyst_date": "2026-05-12",
      "days_to_catalyst": 73,
      "short_interest_pct": 13.09,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "catalyst": 20,
        "fallen_angel": 22,
        "fundamental": 20,
        "social": 15,
        "news_boost": 7,
        "breakout_pattern_bonus": 3,
        "quality_persistence": -2,
        "fundamental_risk": -3,
        "ai_disruption": 15
      },
      "score_trend": [
        82,
        81,
        95,
        95,
        79,
        92,
        92,
        92,
        74,
        92
      ],
      "price_trend": [
        39.9966,
        42.36,
        44.49,
        44.49,
        45.45,
        44.03,
        44.24,
        44.24,
        40.95,
        40.95
      ],
      "trend_direction": "stable",
      "aggregate": {
        "avg_score": 80,
        "peak_score": 95,
        "min_score": 64,
        "buy_pct": 75,
        "price_change_pct": 2.3
      },
      "fundamentals": {
        "pe": 28.4,
        "rev_growth_pct": 59.0,
        "margin_pct": 51.5,
        "target_price": 79.31,
        "target_upside_pct": 93.7,
        "target_median": 80.0,
        "target_high": 125.0,
        "target_low": 37.0
      },
      "insider": {
        "signal": "NEUTRAL",
        "buys": 0,
        "sells": 0,
        "key_insider_buying": false
      },
      "congress": {
        "signal": "MODERATE",
        "buyers": 2,
        "bipartisan": true
      },
      "analyst": {
        "distribution": {
          "strong_buy": 1,
          "buy": 10,
          "hold": 2,
          "sell": 0,
          "strong_sell": 1,
          "total": 14
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {},
      "ai_thesis": "",
      "scans_tracked": 17,
      "first_detected": "2026-02-13T08:58:21.171632",
      "hysteresis_note": "BUY pending (streak 0/2, conf 95)",
      "events": [],
      "checklist": {},
      "checklist_score": 0,
      "quality_framework": "",
      "convergence_signal": false,
      "satellite_fit": 1.09,
      "satellite_score": 59,
      "entry_timing": {
        "score": 61,
        "label": "Wait",
        "recommended_entry": 44.26,
        "rsi": 43.5,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "TTD",
      "score": 92,
      "recommendation": "WATCHLIST",
      "profile": "value",
      "tier": 5,
      "confidence": 56,
      "price": 23.82,
      "market_cap_fmt": "$11.6B",
      "down_from_high_pct": 74.0,
      "catalyst_type": null,
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": 10.61,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "profitability": 18,
        "fcf": 13,
        "discount": 8,
        "sector_panic": 15,
        "pe_discount": 15,
        "no_dilution": 11,
        "convergence_bonus": 8,
        "news_boost": 4,
        "momentum_bonus": 2,
        "breakout_pattern_bonus": 14,
        "claude_enhancement": -1,
        "ai_disruption": 8
      },
      "score_trend": [
        92,
        84,
        83,
        84,
        89,
        92
      ],
      "price_trend": [
        25.5,
        25.16,
        23.95,
        23.95,
        23.82,
        23.82
      ],
      "trend_direction": "improving",
      "aggregate": {
        "avg_score": 87,
        "peak_score": 92,
        "min_score": 83,
        "buy_pct": 100,
        "price_change_pct": -6.6
      },
      "fundamentals": {
        "pe": 27.1,
        "rev_growth_pct": 14.3,
        "margin_pct": 15.3,
        "target_price": 34.98,
        "target_upside_pct": 46.9,
        "target_median": 32.0,
        "target_high": 70.0,
        "target_low": 17.0
      },
      "insider": {
        "signal": "NEUTRAL",
        "buys": 0,
        "sells": 0,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 3,
          "buy": 16,
          "hold": 15,
          "sell": 3,
          "strong_sell": 1,
          "total": 38
        },
        "distribution_shift": {
          "buy_pct_change": -2.6,
          "sell_pct_change": 2.6
        }
      },
      "trajectory": {
        "match": "HIMS",
        "correlation": 0.77,
        "phase": "Launch Ready",
        "months_est": 5.3
      },
      "ai_thesis": "TTD presents a compelling acquisition target at current levels, trading 74% below its 52-week high at a $11.6B market cap that makes it attractive to larger tech giants seeking to consolidate the programmatic advertising space. The stock has been oversold despite maintaining its market-leading position in demand-side platform technology, with 88% bullish sentiment on StockTwits indicating retail confidence is building ahead of potential M&A activity. At $23.82, TTD offers an optimal entry point for investors to capitalize on acquisition premium upside, as the company's strategic value and depressed valuation create a perfect storm for buyout interest.",
      "scans_tracked": 4,
      "first_detected": "2026-02-19T08:39:27.100537",
      "hysteresis_note": "BUY pending (streak 3/2, conf 56)",
      "events": [],
      "checklist": {
        "Profitable": "pass",
        "Strong FCF": "pass",
        "Near 52w Lows": "partial",
        "Sector Panic": "pass",
        "Low PE": "pass",
        "No Dilution": "pass"
      },
      "checklist_score": 5,
      "quality_framework": "value",
      "convergence_signal": true,
      "satellite_fit": 1.09,
      "satellite_score": 59,
      "entry_timing": {
        "score": 80,
        "label": "Enter",
        "recommended_entry": 26.27,
        "rsi": 25.9,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "AGI",
      "score": 80,
      "recommendation": "WATCHLIST",
      "profile": "quality_growth",
      "tier": 6,
      "confidence": 53,
      "price": 54.19,
      "market_cap_fmt": "$22.8B",
      "down_from_high_pct": 0.3,
      "catalyst_type": null,
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": null,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_growth_q": 20,
        "gross_margins_q": 15,
        "nrr": 6,
        "tam": 5,
        "rule40": 20,
        "sbc": 15,
        "convergence_bonus": 8,
        "news_boost": 4,
        "breakout_pattern_bonus": 14,
        "claude_enhancement": 3,
        "ai_disruption": 1,
        "narrative_overlap": -1,
        "low_upside": -10
      },
      "score_trend": [
        78,
        78,
        78,
        78,
        80,
        79,
        77,
        80,
        80
      ],
      "price_trend": [
        49.7,
        50.52,
        50.52,
        50.56,
        50.02,
        52.45,
        52.45,
        54.19,
        54.19
      ],
      "trend_direction": "improving",
      "aggregate": {
        "avg_score": 79,
        "peak_score": 80,
        "min_score": 77,
        "buy_pct": 100,
        "price_change_pct": 9.0
      },
      "fundamentals": {
        "pe": 25.8,
        "rev_growth_pct": 53.1,
        "margin_pct": 49.0,
        "target_price": 56.5,
        "target_upside_pct": 4.3,
        "target_median": 58.5,
        "target_high": 61.0,
        "target_low": 48.0
      },
      "insider": {
        "signal": "NEUTRAL",
        "buys": 0,
        "sells": 0,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 5,
          "buy": 8,
          "hold": 0,
          "sell": 0,
          "strong_sell": 0,
          "total": 13
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "PLTR_2025-05-05",
        "correlation": 0.78,
        "phase": "Launch Ready",
        "months_est": 5.1
      },
      "ai_thesis": "Alamos Gold's record earnings beat and dividend hike announcement has catalyzed a 17% surge while maintaining extremely bullish sentiment (100% StockTwits bullish, +0.67 news sentiment), positioning AGI at its 52-week high with continued momentum potential. The combination of fundamental strength demonstrated by record earnings and the company's confidence in raising dividends creates a compelling entry point, especially with the stock trading at peak levels supported by genuine operational improvements rather than speculative fervor. With a massive $22.8B market cap providing institutional appeal and no insider selling pressure, AGI represents a high-conviction buy on proven earnings power and shareholder-friendly capital allocation.",
      "scans_tracked": 5,
      "first_detected": "2026-02-24T08:47:30.254517",
      "hysteresis_note": "BUY pending (streak 4/2, conf 53)",
      "events": [],
      "checklist": {
        "Revenue Growth": "pass",
        "Gross Margins": "pass",
        "Net Retention": "partial",
        "TAM Opportunity": "partial",
        "Rule of 40": "pass",
        "Low SBC": "pass"
      },
      "checklist_score": 4,
      "quality_framework": "quality_growth",
      "convergence_signal": true,
      "satellite_fit": 1.08,
      "satellite_score": 0,
      "entry_timing": {
        "score": 5,
        "label": "Stretched",
        "recommended_entry": 44.54,
        "rsi": 70.1,
        "risk_reward": 0.19,
        "entry_aging": ""
      }
    },
    {
      "ticker": "GDDY",
      "score": 78,
      "recommendation": "WATCHLIST",
      "profile": "value",
      "tier": 5,
      "confidence": 56,
      "price": 87.16,
      "market_cap_fmt": "$12.1B",
      "down_from_high_pct": 55.0,
      "catalyst_type": null,
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": 6.11,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "profitability": 20,
        "fcf": 20,
        "discount": 15,
        "sector_panic": 15,
        "pe_discount": 15,
        "no_dilution": 8,
        "convergence_bonus": 8,
        "news_boost": 7,
        "breakout_pattern_bonus": 13,
        "fundamental_risk": -4,
        "claude_enhancement": -8,
        "ai_disruption": 3,
        "insider_sell_penalty": -15
      },
      "score_trend": [
        82,
        67,
        70,
        70,
        68,
        78,
        65,
        76,
        78,
        78
      ],
      "price_trend": [
        90.64,
        87.76,
        92.725,
        92.725,
        92.3,
        79.12,
        86.2,
        86.2,
        87.16,
        87.16
      ],
      "trend_direction": "stable",
      "aggregate": {
        "avg_score": 83,
        "peak_score": 111,
        "min_score": 65,
        "buy_pct": 67,
        "price_change_pct": -3.7
      },
      "fundamentals": {
        "pe": 15.0,
        "rev_growth_pct": 6.8,
        "margin_pct": 17.7,
        "target_price": 124.79,
        "target_upside_pct": 43.2,
        "target_median": 102.5,
        "target_high": 200.0,
        "target_low": 77.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 9,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 3,
          "buy": 6,
          "hold": 7,
          "sell": 0,
          "strong_sell": 0,
          "total": 16
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "GPCR",
        "correlation": 0.77,
        "phase": "Coiling",
        "months_est": 7.9
      },
      "ai_thesis": "GoDaddy's 14-21% post-earnings decline has created an attractive entry point at 55% below its 52-week high, as the market has overreacted to softer revenue guidance despite the company beating earnings expectations. The stock's high score of 113/100 combined with 80% bullish sentiment on StockTwits suggests strong retail conviction that the selloff is overdone, while the company's dominant position in domain registration and web hosting provides a solid foundation for recovery. With no immediate negative catalysts on the horizon and the stock trading at a significant technical discount, current levels present a compelling risk-reward opportunity for a bounce back toward recent highs.",
      "scans_tracked": 7,
      "first_detected": "2026-02-18T23:11:02.121941",
      "hysteresis_note": "BUY pending (streak 1/2, conf 56)",
      "events": [],
      "checklist": {
        "Profitable": "pass",
        "Strong FCF": "pass",
        "Near 52w Lows": "pass",
        "Sector Panic": "pass",
        "Low PE": "pass",
        "No Dilution": "partial"
      },
      "checklist_score": 5,
      "quality_framework": "value",
      "convergence_signal": true,
      "satellite_fit": 1.2,
      "satellite_score": 70,
      "entry_timing": {
        "score": 81,
        "label": "Enter",
        "recommended_entry": 91.98,
        "rsi": 39.9,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "BRCTF",
      "score": 75,
      "recommendation": "WATCHLIST",
      "profile": "quality_growth",
      "tier": 6,
      "confidence": 71,
      "price": 38.06,
      "market_cap_fmt": "$3.4B",
      "down_from_high_pct": 0,
      "catalyst_type": "fda",
      "catalyst_date": "2026-05-24",
      "days_to_catalyst": 85,
      "short_interest_pct": null,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_growth_q": 20,
        "gross_margins_q": 20,
        "nrr": 6,
        "tam": 8,
        "rule40": 20,
        "sbc": 5,
        "convergence_bonus": 8,
        "news_boost": 1,
        "breakout_pattern_bonus": 4,
        "ai_disruption": 2
      },
      "score_trend": [
        79,
        75
      ],
      "price_trend": [
        38.06,
        38.06
      ],
      "trend_direction": "new",
      "aggregate": {
        "avg_score": 77,
        "peak_score": 79,
        "min_score": 75,
        "buy_pct": 100,
        "price_change_pct": 0.0
      },
      "fundamentals": {
        "pe": 30.4,
        "rev_growth_pct": 81.8,
        "margin_pct": 51.1
      },
      "insider": {
        "signal": "NEUTRAL",
        "buys": 0,
        "sells": 0,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {},
      "trajectory": {},
      "ai_thesis": "",
      "scans_tracked": 1,
      "first_detected": "2026-02-28T07:34:43.953023",
      "hysteresis_note": "BUY pending (streak 1/2, conf 71)",
      "events": [],
      "checklist": {
        "Revenue Growth": "pass",
        "Gross Margins": "pass",
        "Net Retention": "partial",
        "TAM Opportunity": "pass",
        "Rule of 40": "pass",
        "Low SBC": "partial"
      },
      "checklist_score": 4,
      "quality_framework": "quality_growth",
      "convergence_signal": true,
      "satellite_fit": 1.2,
      "satellite_score": 70,
      "entry_timing": {
        "score": 18,
        "label": "Stretched",
        "recommended_entry": 35.28,
        "rsi": 81.8,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "PYPL",
      "score": 73,
      "recommendation": "WATCHLIST",
      "profile": "value",
      "tier": 5,
      "confidence": 49,
      "price": 46.21,
      "market_cap_fmt": "$43.2B",
      "down_from_high_pct": 41.9,
      "catalyst_type": null,
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": 5.63,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "profitability": 20,
        "fcf": 16,
        "discount": 15,
        "sector_panic": 15,
        "pe_discount": 11,
        "no_dilution": 13,
        "convergence_bonus": 8,
        "news_boost": 9,
        "breakout_pattern_bonus": 11,
        "fundamental_risk": -7,
        "claude_enhancement": -2,
        "ai_disruption": 2,
        "insider_sell_penalty": -10,
        "low_upside": -10
      },
      "score_trend": [
        65,
        76,
        78,
        80,
        74,
        72,
        73,
        67,
        73,
        73
      ],
      "price_trend": [
        41.65,
        44.05,
        43.425,
        43.425,
        47.02,
        47.32,
        45.53,
        45.53,
        46.21,
        46.21
      ],
      "trend_direction": "improving",
      "aggregate": {
        "avg_score": 82,
        "peak_score": 105,
        "min_score": 47,
        "buy_pct": 62,
        "price_change_pct": -11.7
      },
      "fundamentals": {
        "pe": 8.5,
        "rev_growth_pct": 3.7,
        "margin_pct": 15.8,
        "target_price": 51.88,
        "target_upside_pct": 12.3,
        "target_median": 47.0,
        "target_high": 100.0,
        "target_low": 32.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 4,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 2,
          "buy": 8,
          "hold": 31,
          "sell": 4,
          "strong_sell": 0,
          "total": 45
        },
        "distribution_shift": {
          "buy_pct_change": -6.7,
          "sell_pct_change": -2.2
        }
      },
      "trajectory": {
        "match": "UBER",
        "correlation": 0.76,
        "phase": "Coiling",
        "months_est": 10.8
      },
      "ai_thesis": "PayPal's partnership with MoonPay to launch PYUSDx represents a pivotal catalyst positioning the company at the forefront of the rapidly expanding stablecoin infrastructure market, with the current 42% discount from 52-week highs creating an optimal entry point before this crypto initiative gains broader market recognition. Despite concerning insider selling activity, the overwhelmingly bullish retail sentiment (100% on StockTwits) and positive news momentum (+0.46) suggest institutional accumulation at these depressed levels ahead of the platform launch. The $43.2B market cap trades at a significant discount to growth prospects given PayPal's established payment rails now extending into blockchain infrastructure, making this an asymmetric risk-reward opportunity.",
      "scans_tracked": 8,
      "first_detected": "2026-02-03T06:43:01.944105+00:00",
      "hysteresis_note": "",
      "events": [],
      "checklist": {
        "Profitable": "pass",
        "Strong FCF": "pass",
        "Near 52w Lows": "pass",
        "Sector Panic": "pass",
        "Low PE": "pass",
        "No Dilution": "pass"
      },
      "checklist_score": 6,
      "quality_framework": "value",
      "convergence_signal": true,
      "satellite_fit": 1.2,
      "satellite_score": 0,
      "entry_timing": {
        "score": 42,
        "label": "Wait",
        "recommended_entry": 43.32,
        "rsi": 48.4,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "CRWV",
      "score": 69,
      "recommendation": "WATCHLIST",
      "profile": "quality_growth",
      "tier": 6,
      "confidence": 87,
      "price": 79.56,
      "market_cap_fmt": "$41.5B",
      "down_from_high_pct": 57.5,
      "catalyst_type": "earnings",
      "catalyst_date": "2026-05-15",
      "days_to_catalyst": 76,
      "short_interest_pct": 18.86,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_growth_q": 20,
        "gross_margins_q": 15,
        "nrr": 10,
        "tam": 2,
        "rule40": 20,
        "sbc": 10,
        "convergence_bonus": 8,
        "news_boost": 3,
        "momentum_bonus": 7,
        "breakout_pattern_bonus": 10,
        "claude_enhancement": -9,
        "ai_disruption": 18,
        "low_margin": -10,
        "insider_sell_penalty": -25
      },
      "score_trend": [
        35,
        38,
        61,
        67,
        66,
        69,
        71,
        55,
        55,
        69
      ],
      "price_trend": [
        89.25,
        90.84,
        95.89,
        95.89,
        99.3,
        98.01,
        97.63,
        97.63,
        79.56,
        79.56
      ],
      "trend_direction": "improving",
      "aggregate": {
        "avg_score": 55,
        "peak_score": 71,
        "min_score": 35,
        "buy_pct": 0,
        "price_change_pct": -16.9
      },
      "fundamentals": {
        "rev_growth_pct": 110.3,
        "margin_pct": -22.7,
        "target_price": 124.7,
        "target_upside_pct": 56.7,
        "target_median": 120.0,
        "target_high": 251.0,
        "target_low": 41.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 771,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 2,
          "buy": 16,
          "hold": 11,
          "sell": 1,
          "strong_sell": 0,
          "total": 30
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "MU",
        "correlation": 0.72,
        "phase": "Launch Ready",
        "months_est": 5.0
      },
      "ai_thesis": "CRWV presents a compelling acquisition play with a 76-day catalyst timeline, trading 57% below its 52-week high at $79.56 despite an anticipated further 20% Monday decline creating an optimal $5 entry point. The negative insider activity and current oversold technicals have created maximum pessimism ahead of the acquisition announcement, positioning this as a contrarian opportunity with significant upside potential once the catalyst materializes. The combination of deep value pricing, defined timeline, and acquisition premium opportunity makes this an asymmetric risk-reward setup at current levels.",
      "scans_tracked": 8,
      "first_detected": "2026-02-13T12:44:21.032323",
      "hysteresis_note": "",
      "events": [],
      "checklist": {
        "Revenue Growth": "pass",
        "Gross Margins": "pass",
        "Net Retention": "pass",
        "TAM Opportunity": "fail",
        "Rule of 40": "pass",
        "Low SBC": "pass"
      },
      "checklist_score": 5,
      "quality_framework": "quality_growth",
      "convergence_signal": true,
      "satellite_fit": 1.03,
      "satellite_score": 53,
      "entry_timing": {
        "score": 62,
        "label": "Wait",
        "recommended_entry": 91.81,
        "rsi": 40.4,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "DSKYF",
      "score": 68,
      "recommendation": "WATCHLIST",
      "profile": "recovery",
      "tier": 2,
      "confidence": 69,
      "price": 19.53,
      "market_cap_fmt": "$36.1B",
      "down_from_high_pct": 33.0,
      "catalyst_type": "fda",
      "catalyst_date": "2026-06-02",
      "days_to_catalyst": 94,
      "short_interest_pct": null,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "catalyst": 20,
        "fallen_angel": 14,
        "fundamental": 20,
        "social": 10,
        "news_boost": 0,
        "acceleration_influence": -6,
        "breakout_pattern_bonus": 20,
        "fundamental_risk": 5,
        "claude_enhancement": -7,
        "ai_disruption": 3
      },
      "score_trend": [
        64,
        68
      ],
      "price_trend": [
        19.53,
        19.53
      ],
      "trend_direction": "new",
      "aggregate": {
        "avg_score": 66,
        "peak_score": 68,
        "min_score": 64,
        "buy_pct": 0,
        "price_change_pct": 0.0
      },
      "fundamentals": {
        "pe": 20.3,
        "rev_growth_pct": 15.1,
        "margin_pct": 14.8
      },
      "insider": {
        "signal": "NEUTRAL",
        "buys": 0,
        "sells": 0,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {},
      "trajectory": {
        "match": "HIMS",
        "correlation": 0.75,
        "phase": "Launch Ready",
        "months_est": 5.4
      },
      "ai_thesis": "DSKYF presents a compelling entry opportunity ahead of its FDA catalyst in 94 days, with shares trading 33% below 52-week highs at $19.53 despite maintaining a strong BUY score of 82/100. The current neutral market sentiment and insider activity create an asymmetric risk-reward setup, positioning investors to capitalize on potential FDA approval upside while entering at technically attractive levels. With a $36.1B market cap providing institutional liquidity and the stock trading at a significant discount to recent peaks, the next three months offer optimal timing to establish positions before the regulatory decision.",
      "scans_tracked": 1,
      "first_detected": "2026-02-28T07:34:43.904334",
      "hysteresis_note": "",
      "events": [],
      "checklist": {},
      "checklist_score": 0,
      "quality_framework": "",
      "convergence_signal": false,
      "satellite_fit": 0.99,
      "satellite_score": 49,
      "entry_timing": {
        "score": 27,
        "label": "Stretched",
        "recommended_entry": 18.93,
        "rsi": 50.2,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "PLTR",
      "score": 66,
      "recommendation": "WATCHLIST",
      "profile": "quality_growth",
      "tier": 6,
      "confidence": 82,
      "price": 137.19,
      "market_cap_fmt": "$328.1B",
      "down_from_high_pct": 33.9,
      "catalyst_type": "analyst",
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": 2.35,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_growth_q": 20,
        "gross_margins_q": 20,
        "nrr": 10,
        "tam": 2,
        "rule40": 20,
        "sbc": 0,
        "convergence_bonus": 8,
        "news_boost": 8,
        "breakout_pattern_bonus": 8,
        "fundamental_risk": -8,
        "claude_enhancement": -1,
        "ai_disruption": 18,
        "insider_sell_penalty": -25
      },
      "score_trend": [
        65,
        49,
        62,
        63,
        62,
        66,
        66,
        66,
        66,
        66
      ],
      "price_trend": [
        135.24,
        130.6,
        129.332,
        129.332,
        128.84,
        134.19,
        135.94,
        135.94,
        137.19,
        137.19
      ],
      "trend_direction": "stable",
      "aggregate": {
        "avg_score": 61,
        "peak_score": 79,
        "min_score": 43,
        "buy_pct": 9,
        "price_change_pct": -7.2
      },
      "fundamentals": {
        "pe": 217.8,
        "rev_growth_pct": 70.0,
        "margin_pct": 36.3,
        "target_price": 184.49,
        "target_upside_pct": 34.5,
        "target_median": 192.5,
        "target_high": 260.0,
        "target_low": 70.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 63,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 1,
          "buy": 15,
          "hold": 10,
          "sell": 1,
          "strong_sell": 1,
          "total": 28
        },
        "distribution_shift": {
          "buy_pct_change": 31.2,
          "sell_pct_change": -7.7
        }
      },
      "trajectory": {
        "match": "LITE",
        "correlation": 0.72,
        "phase": "Accumulation",
        "months_est": 14.0
      },
      "ai_thesis": "Palantir's new partnership with Innodata for AI data engineering services to the U.S. Missile Defense Agency represents immediate validation of PLTR's defense AI capabilities and should drive near-term revenue acceleration in the high-margin government sector. Trading 34% below its 52-week high at $137.19 despite overwhelmingly bullish retail sentiment (100% on StockTwits), the stock presents an attractive technical entry point before the defense partnership revenue begins flowing through earnings. While insider selling creates near-term pressure, the partnership catalyst should override this headwind as investors recognize PLTR's expanding role in critical national security AI infrastructure.",
      "scans_tracked": 12,
      "first_detected": "2026-02-03T06:49:57.002264+00:00",
      "hysteresis_note": "",
      "events": [
        {
          "type": "analyst_upgrade",
          "date": null,
          "summary": "Palantir upgraded to Outperform from Neutral by Mizuho with $195 price target amid AI partnership and defense contract.",
          "direction": "bull"
        }
      ],
      "checklist": {
        "Revenue Growth": "pass",
        "Gross Margins": "pass",
        "Net Retention": "pass",
        "TAM Opportunity": "fail",
        "Rule of 40": "pass",
        "Low SBC": "fail"
      },
      "checklist_score": 4,
      "quality_framework": "quality_growth",
      "convergence_signal": true,
      "satellite_fit": 0.6,
      "satellite_score": 10,
      "entry_timing": {
        "score": 55,
        "label": "Wait",
        "recommended_entry": 137.08,
        "rsi": 43.0,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "MNKD",
      "score": 49,
      "recommendation": "MOMENTUM",
      "profile": "quality_growth",
      "tier": 6,
      "confidence": 90,
      "price": 3.28,
      "market_cap_fmt": "$1.0B",
      "down_from_high_pct": 49.6,
      "catalyst_type": "fda",
      "catalyst_date": "2026-05-29",
      "days_to_catalyst": 90,
      "short_interest_pct": 8.66,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_growth_q": 15,
        "gross_margins_q": 15,
        "nrr": 6,
        "tam": 8,
        "rule40": 10,
        "sbc": 10,
        "convergence_bonus": 8,
        "news_boost": 6,
        "breakout_pattern_bonus": 8,
        "claude_enhancement": -9,
        "ai_disruption": 2,
        "low_margin": -10,
        "insider_sell_penalty": -15
      },
      "score_trend": [
        50,
        49
      ],
      "price_trend": [
        3.28,
        3.28
      ],
      "trend_direction": "new",
      "aggregate": {
        "avg_score": 50,
        "peak_score": 50,
        "min_score": 49,
        "buy_pct": 0,
        "price_change_pct": 0.0
      },
      "fundamentals": {
        "pe": 32.8,
        "rev_growth_pct": 45.8,
        "margin_pct": 1.7,
        "target_price": 8.5,
        "target_upside_pct": 159.1,
        "target_median": 8.0,
        "target_high": 10.0,
        "target_low": 7.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 6,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 1,
          "buy": 8,
          "hold": 0,
          "sell": 0,
          "strong_sell": 0,
          "total": 9
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {},
      "ai_thesis": "MNKD presents a compelling contrarian opportunity with its partner United Therapeutics set to launch a potentially transformative \"category killer product\" within 90 days, while the stock trades 50% below its 52-week high at $3.28 following an overreaction selloff. The negative insider activity and recent plunge have created an optimal entry point ahead of the product launch catalyst, with bullish retail sentiment at 70% suggesting institutional pessimism may be overdone. This risk-reward setup offers significant upside potential as the market begins to price in the commercial prospects of the new therapeutic launch over the next quarter.",
      "scans_tracked": 1,
      "first_detected": "2026-02-28T07:34:44.006768",
      "hysteresis_note": "",
      "events": [],
      "checklist": {
        "Revenue Growth": "pass",
        "Gross Margins": "pass",
        "Net Retention": "partial",
        "TAM Opportunity": "pass",
        "Rule of 40": "partial",
        "Low SBC": "pass"
      },
      "checklist_score": 4,
      "quality_framework": "quality_growth",
      "convergence_signal": true,
      "satellite_fit": 1.39,
      "satellite_score": 89,
      "entry_timing": {
        "score": 70,
        "label": "Wait",
        "recommended_entry": 5.35,
        "rsi": 19.0,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "ASTS",
      "score": 46,
      "recommendation": "MOMENTUM",
      "profile": "recovery",
      "tier": 2,
      "confidence": 98,
      "price": 79.19,
      "market_cap_fmt": "$30.1B",
      "down_from_high_pct": 39.0,
      "catalyst_type": "earnings",
      "catalyst_date": "2026-05-11",
      "days_to_catalyst": 72,
      "short_interest_pct": 19.58,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "catalyst": 20,
        "fallen_angel": 15,
        "fundamental": 15,
        "social": 15,
        "news_boost": 9,
        "acceleration_influence": -7,
        "pre_revenue_discount": -7,
        "claude_enhancement": -2,
        "ai_disruption": 2,
        "low_margin": -10,
        "low_upside": -10
      },
      "score_trend": [
        39,
        40,
        40,
        43,
        42,
        42,
        46,
        39,
        47,
        46
      ],
      "price_trend": [
        80.2,
        83.98,
        83.98,
        83.9,
        84.2,
        84.2,
        82.36,
        85.76,
        79.19,
        79.19
      ],
      "trend_direction": "improving",
      "aggregate": {
        "avg_score": 48,
        "peak_score": 66,
        "min_score": 39,
        "buy_pct": 0,
        "price_change_pct": -21.4
      },
      "fundamentals": {
        "rev_growth_pct": 12.4,
        "margin_pct": 0.0,
        "target_price": 80.39,
        "target_upside_pct": 1.5,
        "target_median": 81.25,
        "target_high": 137.0,
        "target_low": 43.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 3,
        "sells": 4,
        "key_insider_buying": true
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 0,
          "buy": 3,
          "hold": 5,
          "sell": 0,
          "strong_sell": 2,
          "total": 10
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {},
      "ai_thesis": "AST SpaceMobile secured a meaningful $30M government contract validating its satellite-communications technology and opening doors to additional U.S. Space Force/DoD contracts. Strong retail sentiment (88% bullish on StockTwits) and positive news aggregation (+0.40) suggest growing market interest in the space-comms sector play.",
      "scans_tracked": 20,
      "first_detected": "2026-02-10T20:25:59.438167",
      "hysteresis_note": "",
      "events": [
        {
          "type": "contract_award",
          "date": null,
          "summary": "AST SpaceMobile secured a prime contract position on the US Missile Defense Agency's Shield program as part of the Pentagon's Golden Dome defense strategy.",
          "direction": "bull"
        },
        {
          "type": "contract_award",
          "date": "2026-02-23",
          "summary": "AST SpaceMobile USA secured its first $30 million SDA prime contract for the Europa Track 2 Commercial Solutions program to support the military's transport layer of communications and data relay sate",
          "direction": "bull"
        },
        {
          "type": "satellite_deployment",
          "date": null,
          "summary": "AST SpaceMobile planning multi-launcher campaign with one orbital launch every one to two months during 2026, with BlueBird 7 scheduled for late February on New Glenn-3 mission.",
          "direction": "bull"
        },
        {
          "type": "launch",
          "date": "2026-02-23",
          "summary": "AST SpaceMobile's BlueBird 7 launch is scheduled for late February 2026 on the New Glenn-3 mission from Cape Canaveral Space Force Station.",
          "direction": "bull"
        },
        {
          "type": "launch",
          "date": "2026-06-30",
          "summary": "AST SpaceMobile targeting 45-60 satellite launches in 2026 with one orbital launch every one to two months on average.",
          "direction": "bull"
        },
        {
          "type": "mission_launch",
          "date": null,
          "summary": "AST SpaceMobile targeting launch of 45-60 satellites in 2026 with over $1 billion in contracted commercial revenue commitments.",
          "direction": "bull"
        },
        {
          "type": "government_contract",
          "date": null,
          "summary": "AST SpaceMobile secured a prime position on the US Missile Defense Agency's Shield program under a multi-year IDIQ contract for research, development, engineering, and operations.",
          "direction": "bull"
        },
        {
          "type": "product_development",
          "date": null,
          "summary": "AST SpaceMobile executing Block 2 satellite launches over next two quarters with target of launching 45-60 satellites in 2026.",
          "direction": "bull"
        },
        {
          "type": "launch_campaign",
          "date": null,
          "summary": "AST SpaceMobile plans a multi-launcher campaign with one orbital launch every one to two months on average throughout 2026.",
          "direction": "bull"
        },
        {
          "type": "launch_window",
          "date": null,
          "summary": "AST SpaceMobile aims to launch between 45 and 60 satellites in 2026.",
          "direction": "bull"
        },
        {
          "type": "business_update",
          "date": "2026-03-02",
          "summary": "AST SpaceMobile will hold a quarterly business update call on March 2, 2026 at 5 PM ET to address questions from retail and institutional shareholders regarding business and financial results.",
          "direction": "neutral"
        },
        {
          "type": "launch_window",
          "date": "2026-02-28",
          "summary": "AST SpaceMobile planned multi-launcher campaign with BlueBird 7 launch scheduled for late February 2026 on New Glenn-3 mission from Cape Canaveral Space Force Station.",
          "direction": "bull"
        },
        {
          "type": "mission_launch",
          "date": "2026-03-31",
          "summary": "AST SpaceMobile planning multi-launcher campaign with one orbital launch every one to two months on average during 2026, with BlueBird 7 scheduled for late February on New Glenn-3 mission.",
          "direction": "bull"
        },
        {
          "type": "launch",
          "date": null,
          "summary": "AST SpaceMobile plans Block 2 BlueBird satellite launches over the next two quarters in 2026.",
          "direction": "bull"
        }
      ],
      "checklist": {},
      "checklist_score": 0,
      "quality_framework": "",
      "convergence_signal": false,
      "satellite_fit": 1.03,
      "satellite_score": 0,
      "entry_timing": {
        "score": 65,
        "label": "Wait",
        "recommended_entry": 92.06,
        "rsi": 41.3,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "AXSM",
      "score": 46,
      "recommendation": "MOMENTUM",
      "profile": "quality_growth",
      "tier": 6,
      "confidence": 92,
      "price": 163.89,
      "market_cap_fmt": "$8.4B",
      "down_from_high_pct": 14.4,
      "catalyst_type": "fda",
      "catalyst_date": "2026-04-30",
      "days_to_catalyst": 61,
      "short_interest_pct": 6.34,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_growth_q": 20,
        "gross_margins_q": 20,
        "nrr": 6,
        "tam": 8,
        "rule40": 0,
        "sbc": 5,
        "convergence_bonus": 8,
        "news_boost": 6,
        "breakout_pattern_bonus": 14,
        "claude_enhancement": -4,
        "ai_disruption": 2,
        "low_margin": -10,
        "insider_sell_penalty": -25
      },
      "score_trend": [
        44,
        46
      ],
      "price_trend": [
        163.89,
        163.89
      ],
      "trend_direction": "new",
      "aggregate": {
        "avg_score": 45,
        "peak_score": 46,
        "min_score": 44,
        "buy_pct": 0,
        "price_change_pct": 0.0
      },
      "fundamentals": {
        "rev_growth_pct": 65.0,
        "margin_pct": -28.7,
        "target_price": 222.47,
        "target_upside_pct": 35.7,
        "target_median": 220.0,
        "target_high": 260.0,
        "target_low": 198.82
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 13,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 3,
          "buy": 16,
          "hold": 1,
          "sell": 0,
          "strong_sell": 0,
          "total": 20
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "GE",
        "correlation": 0.79,
        "phase": "Accumulation",
        "months_est": 12.9
      },
      "ai_thesis": "AXSM presents a compelling entry opportunity ahead of its FDA catalyst in approximately 61 days, with shares trading 14% below 52-week highs at $163.89 despite maintaining strong retail sentiment (71% bullish on StockTwits). The current technical dislocation, combined with negative insider activity creating temporary selling pressure, has created an attractive risk-reward setup for investors willing to position ahead of the binary FDA decision. With a high conviction score of 90/100 and positive news sentiment of +0.35, the market appears to be undervaluing the probability of a favorable regulatory outcome.",
      "scans_tracked": 1,
      "first_detected": "2026-02-28T07:34:43.958198",
      "hysteresis_note": "",
      "events": [],
      "checklist": {
        "Revenue Growth": "pass",
        "Gross Margins": "pass",
        "Net Retention": "partial",
        "TAM Opportunity": "pass",
        "Rule of 40": "fail",
        "Low SBC": "partial"
      },
      "checklist_score": 3,
      "quality_framework": "quality_growth",
      "convergence_signal": true,
      "satellite_fit": 1.33,
      "satellite_score": 83,
      "entry_timing": {
        "score": 66,
        "label": "Wait",
        "recommended_entry": 179.91,
        "rsi": 33.1,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "REPL",
      "score": 42,
      "recommendation": "MOMENTUM",
      "profile": "recovery",
      "tier": 1,
      "confidence": 71,
      "price": 7.65,
      "market_cap_fmt": "$632M",
      "down_from_high_pct": 42.2,
      "catalyst_type": "fda",
      "catalyst_date": "2026-04-10",
      "days_to_catalyst": 41,
      "short_interest_pct": 33.71,
      "squeeze_potential": true,
      "squeeze_reasons": [
        "SI 33.7% + catalyst + 11.3 days-to-cover"
      ],
      "breakdown": {
        "catalyst": 40,
        "social": 0,
        "technical": 8,
        "fundamental": 10,
        "news_boost": 0,
        "breakout_pattern_bonus": 8,
        "catalyst_pattern_bonus": 12,
        "catalyst_trajectory_phase": 0.896,
        "claude_enhancement": -8,
        "ai_disruption": 2,
        "low_margin": -10,
        "insider_sell_penalty": -10
      },
      "score_trend": [
        42,
        42
      ],
      "price_trend": [
        7.65,
        7.65
      ],
      "trend_direction": "new",
      "aggregate": {
        "avg_score": 42,
        "peak_score": 42,
        "min_score": 42,
        "buy_pct": 0,
        "price_change_pct": 0.0
      },
      "fundamentals": {
        "margin_pct": 0.0,
        "target_price": 12.86,
        "target_upside_pct": 68.1,
        "target_median": 12.0,
        "target_high": 19.0,
        "target_low": 10.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 2,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 1,
          "buy": 4,
          "hold": 2,
          "sell": 0,
          "strong_sell": 0,
          "total": 7
        },
        "distribution_shift": {
          "buy_pct_change": -3.6,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "PLTR_2025-05-05",
        "correlation": 0.74,
        "phase": "Coiling",
        "months_est": 10.5,
        "catalyst_match": "HIMS",
        "catalyst_correlation": 0.71,
        "catalyst_phase": "Catalyst Imminent",
        "catalyst_months": 1.2
      },
      "ai_thesis": "REPL presents a compelling BUY opportunity ahead of its FDA catalyst in 41 days, with shares trading 42% below 52-week highs at $7.65, creating an attractive risk-reward setup for potential regulatory approval upside. The current neutral sentiment (50% bullish on StockTwits) and absence of insider buying in 90 days suggests the market is underestimating the FDA decision probability, positioning patient investors to capitalize on any positive regulatory outcome. With a strong 84/100 score well above the 75 BUY threshold, the technical setup combined with the defined 6-week catalyst timeline offers a clear entry point before potential volatility expansion.",
      "scans_tracked": 1,
      "first_detected": "2026-02-28T07:34:43.964251",
      "hysteresis_note": "",
      "events": [],
      "checklist": {},
      "checklist_score": 0,
      "quality_framework": "",
      "convergence_signal": false,
      "satellite_fit": 1.32,
      "satellite_score": 82,
      "entry_timing": {
        "score": 77,
        "label": "Enter",
        "recommended_entry": 7.76,
        "rsi": 45.5,
        "risk_reward": null,
        "entry_aging": ""
      }
    },
    {
      "ticker": "DTE",
      "score": 38,
      "recommendation": "MOMENTUM",
      "profile": "acceleration",
      "tier": 3,
      "confidence": 22,
      "price": 148.24,
      "market_cap_fmt": "$30.8B",
      "down_from_high_pct": 4.1,
      "catalyst_type": null,
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": 2.29,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_momentum": 17,
        "margin_expansion": 7,
        "price_trend": 14,
        "volume_expansion": 3,
        "conviction": 4,
        "social_discovery": 7,
        "breakout_pattern_bonus": 17,
        "claude_enhancement": -3,
        "ai_disruption": 1,
        "low_margin": -10,
        "low_upside": -10
      },
      "score_trend": [
        40,
        32,
        32,
        34,
        36,
        36,
        36,
        36,
        38,
        38
      ],
      "price_trend": [
        145.03,
        145.85,
        144.04,
        144.04,
        146.09,
        146.02,
        146.59,
        146.59,
        148.24,
        148.24
      ],
      "trend_direction": "stable",
      "aggregate": {
        "avg_score": 40,
        "peak_score": 57,
        "min_score": 32,
        "buy_pct": 0,
        "price_change_pct": 4.2
      },
      "fundamentals": {
        "pe": 21.1,
        "rev_growth_pct": 28.9,
        "margin_pct": 9.2,
        "target_price": 151.5,
        "target_upside_pct": 2.2,
        "target_median": 152.0,
        "target_high": 168.0,
        "target_low": 139.0
      },
      "insider": {
        "signal": "NEUTRAL",
        "buys": 0,
        "sells": 0,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 1,
          "buy": 8,
          "hold": 8,
          "sell": 0,
          "strong_sell": 0,
          "total": 17
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "COIN_2025-05-19",
        "correlation": 0.71,
        "phase": "Launch Ready",
        "months_est": 5.6
      },
      "ai_thesis": "DTE is a large-cap utility with stable fundamentals trading only 4% below highs, suggesting relative strength in the sector. The moderate Reddit engagement (62 mentions) indicates some retail interest without excessive speculation.",
      "scans_tracked": 6,
      "first_detected": "2026-02-18T21:55:00.597346",
      "hysteresis_note": "",
      "events": [],
      "checklist": {},
      "checklist_score": 0,
      "quality_framework": "",
      "convergence_signal": false,
      "satellite_fit": 0.73,
      "satellite_score": 0,
      "entry_timing": {
        "score": 9,
        "label": "Stretched",
        "recommended_entry": 140.91,
        "rsi": 75.7,
        "risk_reward": 0.25,
        "entry_aging": ""
      }
    },
    {
      "ticker": "ETN",
      "score": 38,
      "recommendation": "MOMENTUM",
      "profile": "acceleration",
      "tier": 3,
      "confidence": 53,
      "price": 375.92,
      "market_cap_fmt": "$146.3B",
      "down_from_high_pct": 8.0,
      "catalyst_type": null,
      "catalyst_date": null,
      "days_to_catalyst": null,
      "short_interest_pct": 2.01,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_momentum": 8,
        "margin_expansion": 12,
        "price_trend": 12,
        "volume_expansion": 3,
        "conviction": 7,
        "social_discovery": 4,
        "breakout_pattern_bonus": 17,
        "claude_enhancement": -3,
        "ai_disruption": 2,
        "insider_sell_penalty": -5,
        "low_upside": -10
      },
      "score_trend": [
        41,
        33,
        37,
        37,
        37,
        34,
        34,
        34,
        38,
        38
      ],
      "price_trend": [
        373.38,
        373.38,
        377.205,
        377.205,
        374.56,
        373.53,
        374.59,
        374.59,
        375.92,
        375.92
      ],
      "trend_direction": "improving",
      "aggregate": {
        "avg_score": 42,
        "peak_score": 56,
        "min_score": 33,
        "buy_pct": 0,
        "price_change_pct": -1.3
      },
      "fundamentals": {
        "pe": 36.0,
        "rev_growth_pct": 13.1,
        "margin_pct": 14.9,
        "target_price": 407.52,
        "target_upside_pct": 8.4,
        "target_median": 413.5,
        "target_high": 545.0,
        "target_low": 321.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 1,
        "key_insider_buying": false
      },
      "congress": {
        "signal": "STRONG",
        "buyers": 4,
        "bipartisan": true
      },
      "analyst": {
        "distribution": {
          "strong_buy": 7,
          "buy": 15,
          "hold": 7,
          "sell": 0,
          "strong_sell": 1,
          "total": 30
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 3.3
        }
      },
      "trajectory": {
        "match": "COIN_2024-02-26",
        "correlation": 0.7,
        "phase": "Accumulation",
        "months_est": 12.0
      },
      "ai_thesis": "ETN is a large-cap industrial stock with an established market position, trading only 8% below recent highs which suggests relative stability. The base score of 63/100 indicates a moderately attractive opportunity, though without near-term catalysts.",
      "scans_tracked": 7,
      "first_detected": "2026-02-18T21:55:00.608562",
      "hysteresis_note": "",
      "events": [
        {
          "type": "sector_outperformance",
          "date": null,
          "summary": "Eaton, an industrial equipment manufacturer, is showing strong technical setups as industrials sector outpaces tech in early 2026.",
          "direction": "bull"
        }
      ],
      "checklist": {},
      "checklist_score": 0,
      "quality_framework": "",
      "convergence_signal": false,
      "satellite_fit": 0.77,
      "satellite_score": 0,
      "entry_timing": {
        "score": 36,
        "label": "Stretched",
        "recommended_entry": 374.01,
        "rsi": 56.7,
        "risk_reward": 1.09,
        "entry_aging": ""
      }
    },
    {
      "ticker": "TVTX",
      "score": 37,
      "recommendation": "MOMENTUM",
      "profile": "quality_growth",
      "tier": 6,
      "confidence": 92,
      "price": 29.79,
      "market_cap_fmt": "$2.7B",
      "down_from_high_pct": 29.3,
      "catalyst_type": "fda",
      "catalyst_date": "2026-04-13",
      "days_to_catalyst": 44,
      "short_interest_pct": 17.13,
      "squeeze_potential": false,
      "squeeze_reasons": [],
      "breakdown": {
        "revenue_growth_q": 20,
        "gross_margins_q": 8,
        "nrr": 3,
        "tam": 8,
        "rule40": 20,
        "sbc": 10,
        "convergence_bonus": 8,
        "news_boost": 3,
        "breakout_pattern_bonus": 17,
        "claude_enhancement": -5,
        "ai_disruption": 3,
        "controversy_penalty": -5,
        "low_margin": -10,
        "insider_sell_penalty": -30,
        "controversy_insider_compound": -10
      },
      "score_trend": [
        65,
        66,
        54,
        37
      ],
      "price_trend": [
        27.82,
        28.24,
        27.87,
        29.79
      ],
      "trend_direction": "declining",
      "aggregate": {
        "avg_score": 56,
        "peak_score": 66,
        "min_score": 37,
        "buy_pct": 0,
        "price_change_pct": 7.1
      },
      "fundamentals": {
        "rev_growth_pct": 73.4,
        "margin_pct": -5.2,
        "target_price": 42.71,
        "target_upside_pct": 43.4,
        "target_median": 43.0,
        "target_high": 49.0,
        "target_low": 31.0
      },
      "insider": {
        "signal": "NEGATIVE",
        "buys": 0,
        "sells": 28,
        "key_insider_buying": false
      },
      "congress": {},
      "analyst": {
        "distribution": {
          "strong_buy": 1,
          "buy": 12,
          "hold": 2,
          "sell": 0,
          "strong_sell": 0,
          "total": 15
        },
        "distribution_shift": {
          "buy_pct_change": 0.0,
          "sell_pct_change": 0.0
        }
      },
      "trajectory": {
        "match": "APLD",
        "correlation": 0.74,
        "phase": "Coiling",
        "months_est": 8.4
      },
      "ai_thesis": "TVTX presents a compelling buy opportunity ahead of its FSGS PDUFA decision in 44 days, with FILSPARI already demonstrating strong revenue traction and narrowing losses, positioning the company for significant catalyst-driven upside. The current entry point at $29.79 represents a 29% discount from 52-week highs despite strong fundamentals, while negative sentiment (33% bullish on StockTwits, -0.22 news sentiment) and absent insider buying have created an oversold condition that should reverse sharply on positive regulatory news. The risk-reward profile is highly favorable with FILSPARI's proven commercial success providing a revenue foundation and the pending FSGS approval offering substantial market expansion potential within the next six weeks.",
      "scans_tracked": 1,
      "first_detected": "2026-02-14T17:17:32.483507",
      "hysteresis_note": "",
      "events": [
        {
          "type": "pdufa_date",
          "date": null,
          "summary": "Travere Therapeutics has a PDUFA date for sNDA of FILSPARI for focal segmental glomerulosclerosis on January 13, 2026.",
          "direction": "neutral"
        },
        {
          "type": "fda_pdufa",
          "date": null,
          "summary": "Travere Therapeutics has a PDUFA decision date for FILSPARI (sNDA) for focal segmental glomerulosclerosis treatment.",
          "direction": "neutral"
        }
      ],
      "checklist": {
        "Revenue Growth": "pass",
        "Gross Margins": "partial",
        "Net Retention": "fail",
        "TAM Opportunity": "pass",
        "Rule of 40": "pass",
        "Low SBC": "pass"
      },
      "checklist_score": 4,
      "quality_framework": "quality_growth",
      "convergence_signal": true,
      "satellite_fit": 1.26,
      "satellite_score": 76,
      "entry_timing": {
        "score": 80,
        "label": "Enter",
        "recommended_entry": 30.18,
        "rsi": 46.9,
        "risk_reward": null,
        "entry_aging": ""
      }
    }
  ]
}